Integrative proteogenomic and pharmacological landscape of acute myeloid leukaemia (IMAGE)

Science China Press

Integrative proteogenomic and pharmacological landscape of acute myeloid leukaemia

Caption

Figure 3. The drug sensitivity patterns of the 77 inhibitors in 56 AML patient samples. Approved drugs for AML treatment are marked in red and drugs in clinical stage are marked in blue.

Credit

©Science China Press

Usage Restrictions

Use with credit.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.